Breast Implant Illness (BII): What We Know

Breast Implant Illness (BII) is a patient-driven term used to describe a broad range of systemic symptoms that some individuals attribute to their breast implants. It remains an evolving area of medicine—shaped by patient experience, emerging research, and ongoing regulatory oversight.

Why This Matters

For many people, breast implants enhance quality of life, body image, and confidence.
For others, however, implant placement is followed by the onset of persistent, often debilitating symptoms such as fatigue, cognitive difficulty (“brain fog”), joint pain, rashes, hair loss, or mood changes. The clustering and timing of symptoms have led patients and clinicians to question whether implants may play a role.

These experiences have prompted a wave of research, regulatory review, and increased awareness among healthcare professionals.

What People Mean by “BII”

“Breast Implant Illness” is not a single, formally recognized medical diagnosis. Instead, it functions as an umbrella term for a varied group of non-specific symptoms that may start or worsen after receiving implants.

Commonly reported symptoms include:

• Chronic fatigue and sleep disturbances
• “Brain fog,” memory or concentration issues
• Joint and muscle pain
• Rashes, hair thinning or loss, and other skin changes
• Anxiety, mood shifts, and palpitations

Because these symptoms overlap with many unrelated medical conditions, a thoughtful medical assessment and clear symptom timeline are essential.

Health authorities acknowledge these patient reports and continue to investigate possible associations, even while the underlying mechanisms remain uncertain.

What the Research Says

1. Evidence is growing—but remains mixed

Systematic reviews show that many individuals reporting BII symptoms experience improvement after explantation (implant removal). However, existing studies vary widely in methods, definitions, and quality. Most available data come from observational studies, which limits certainty.

2. Mechanisms are still unclear

Several hypotheses have been proposed, including:

• Chronic inflammation
• Immune reactions to implant materials or silicone degradation
• Bacterial biofilm triggering immune responses
• Unrelated medical issues coincidentally emerging after augmentation

At present, no single biomarker, lab test, or imaging finding definitively identifies BII.

3. Regulatory agencies are paying attention

Organizations such as the U.S. FDA and Health Canada have issued safety communications, strengthened informed-consent requirements, and expanded surveillance for systemic symptoms and rare implant-associated cancers (such as BIA-ALCL and the extremely rare capsule-associated squamous cell carcinoma).

Outcomes After Explantation

Many—but not all—patients report symptom improvement after implant removal. Improvements range from partial to dramatic, and results vary by individual.

Factors influencing outcomes may include:

• Duration of symptoms
• Presence of coexisting health conditions
• Whether a total capsulectomy is performed
• Underlying immune or inflammatory tendencies

Because outcomes are variable, decisions about explantation should be personalized and informed by a clinician experienced with implant-related concerns.

What to Do If You Think You Have BII

1. Start with a full medical evaluation

Symptoms such as fatigue, brain fog, or joint pain can stem from thyroid imbalance, autoimmune disease, anemia, perimenopause, infections, chronic stress, sleep disorders, mental-health conditions, and more.

2. Track your symptoms

A clear timeline—when symptoms began, how they fluctuate, and how they relate to your implants—helps guide diagnosis and decision-making.

3. Consult clinicians familiar with breast implants

This may include a plastic surgeon plus relevant specialists (rheumatology, dermatology, infectious disease, etc.).

4. Discuss explantation candidly

Ask about:

• Whether implant removal or total capsulectomy is recommended
• Expected recovery
• Realistic likelihood of symptom improvement
• Surgical risks

5. Report your symptoms

• Canada: Health Canada + your healthcare provider + the manufacturer
• S.: FDA MedWatch
• Most countries have equivalent systems

Reporting supports better safety monitoring and research.

How Clinicians Are Approaching BII

Current professional guidance emphasizes:

• Listening to patients without dismissal
• Taking symptoms seriously and investigating appropriately
• Using shared decision-making
• Offering multidisciplinary support when needed
• Providing balanced, evidence-informed counseling on risks, uncertainties, and management options

Clinicians are increasingly aware of BII as a meaningful cluster of patient experiences—even as research continues to catch up.

Key Takeaways

• BII refers to real, sometimes life-disrupting symptoms reported by people with breast implants, even though it is not a formally defined medical condition.
• Research suggests many individuals experience symptom improvement after explantation, but results vary and studies are still developing.
• If you have concerning symptoms, ensure a thorough evaluation, consult clinicians experienced with implants, and consider all options—surgical and non-surgical.

References & Further Reading

1. Kabir R., et al. Breast Implant Illness as a Clinical Entity: A Systematic Review. 2024.
2. U.S. Food and Drug Administration. Breast Implants / Safety Communications.
3. Mayo Clinic. Breast implants: What to know.
4. NHS / GOV.UK. Symptoms sometimes referred to as breast implant illness; BIA-ALCL information.
5. Ferreira S., et al. Comprehensive Systematic Review of Breast Implant Illness. Aesthetic Plast Surg. 2025.
6. BreastCancer.org. What Is Breast Implant Illness (BII)?